The diabetes drug market is poised for substantial growth in the coming years, driven by key factors such as the increasing prevalence of diabetes, rising obesity rates, and the development of new and innovative medications. In 2023, North America led the market, with a significant share attributed to its high diabetes prevalence, the presence of influential organizations like the American Diabetes Association, and the introduction of new medications.